January 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreDecember 24, 2025
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreNovember 13, 2025
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreNovember 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreJanuary 02, 2026
According to market projections, the respiratory infections antibiotics market was valued at USD 10.83 billion in 2026 and is projected to reach USD 17.01 billion by 2035, growing at a CAGR of 5.14%. The report delivers in-depth analysis across antibiotic class, route of administration, indication, healthcare setting, and regions including North Am...
December 30, 2025
According to market projections, the sulfonamides market was valued at USD 1.91 billion in 2025 and is projected to grow from USD 1.97 billion in 2026 to USD 2.7 billion by 2035, registering a CAGR of 3.54% during the forecast period. The sulfonamides market report provides detailed coverage of product types, applications, routes of administration,...
December 29, 2025
The therapeutic neurotoxin market was valued at USD 6.39 billion in 2025 and is projected to reach USD 6.94 billion in 2026, expanding to approximately USD 14.5 billion by 2035 at a CAGR of 8.54% 2026 to 2035. The report covers detailed segment analysis by neurotoxin type, end users, and route of administration....
December 26, 2025
The market is growing due to the rising prevalence of atopic diseases like dermatitis and asthma, coupled with increasing demand for advanced biologically targeted therapies. Growing awareness, better diagnostics, and expanding healthcare access are also fueling market expansion....
December 26, 2025
The emerging need for oral medicines is due to the progression of diabetes, inadequate lifestyle management, and declining insulin production. North America dominated the market in 2024, driven by the growing aging population, innovative drug treatments, and improved access and affordability....
December 16, 2025
According to market projections, small molecule inhibitor market was valued at USD 310.38 billion in 2025 and is expected to reach USD 328.22 billion by 2026, further expanding to around USD 542.87 billion by 2035, growing at a CAGR of 5.75% from 2026 to 2035....
December 12, 2025
The human insulin market is expanding steadily, rising from USD 20.97 billion in 2026 to USD 27.68 billion by 2035 at a CAGR of 3.13%, driven by increasing diabetes cases globally. This report covers complete segmentation by product, formulation, end user, application, and distribution channel, showing rapid-acting insulin holding a 50% share, whil...
December 12, 2025
The pharmacovigilance market is valued at USD 9.61 billion in 2026 and is projected to reach USD 16.87 billion by 2035, expanding at a CAGR of 6.45%.This market report covers detailed segmentation by service type with case processing leading at 31.3% in 2025, type outsourced segment commanding 72.4%, process flow (Phase IV holding 34.5%, and end us...
December 12, 2025
The anesthesia and muscle relaxants market is valued at USD 8.41 billion in 2026 and is projected to reach USD 12.65 billion by 2035, growing at a steady CAGR of 4.64%. This report covers a complete analysis of market segments drug types, route of administration, application, end users, and distribution channels....
November 28, 2025
Projections indicate that, birth control pills industry is projected to rise from USD 19.48 billion in 2025 to USD 30.63 billion by 2035, reflecting a CAGR of 4.63% over the next decade.The birth control pills market is expanding due to its growing innovations and approvals. North America led the market due to the growth in reproductive health awar...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com